Cancer Immunology, Immunotherapy

, 60:1503

The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure

  • Romina Molinari
  • Donatella D’Eliseo
  • Laura Manzi
  • Lello Zolla
  • Francesca Velotti
  • Nicolò Merendino
Short communication

DOI: 10.1007/s00262-011-1074-7

Cite this article as:
Molinari, R., D’Eliseo, D., Manzi, L. et al. Cancer Immunol Immunother (2011) 60: 1503. doi:10.1007/s00262-011-1074-7

Abstract

Some anticancer chemotherapeutics, such as anthracyclines and oxaliplatin, elicit immunogenic apoptosis, meaning that dying cancer cells are engulfed by dendritic cells and tumor antigens are efficiently presented to CD8+ T cells, which control residual tumor cells. Immunogenic apoptosis is characterized by pre-apoptotic cell surface exposure of calreticulin (CRT), which usually resides into the endoplasmic reticulum. We investigated the ability of the n3-polyunsaturated fatty acid docosahexaenoic acid (22:6n3, DHA) to induce pre-apoptotic CRT exposure on the surface of the human PaCa-44 pancreatic and EJ bladder cancer cell lines. Cells were treated with 150 μM DHA for different time periods, and, by immunoblot and immunofluorescence, we showed that DHA induced CRT exposure, before the apoptosis-associated phosphatidylserine exposure. As for the known immunogenic compounds, CRT exposure was inhibited by the antioxidant GSH, the pan-caspase zVAD-FMK, and caspase-8 IETD-FMK inhibitor. We provide the first evidence that DHA induces CRT exposure, representing thus a novel potential anticancer immunogenic chemotherapeutic agent.

Keywords

Docosahexaenoic acidCalreticulinImmunogenic apoptosisImmunochemotherapy

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Romina Molinari
    • 1
  • Donatella D’Eliseo
    • 1
    • 2
  • Laura Manzi
    • 1
  • Lello Zolla
    • 1
  • Francesca Velotti
    • 1
    • 2
  • Nicolò Merendino
    • 1
  1. 1.Department of Ecological and Biological Sciences (DEB)Tuscia UniversityViterboItaly
  2. 2.Centro Ricerca SperimentaleRegina Elena Cancer InstituteRomeItaly